CyberIntel ⬡ News
★ Saved ◆ Cyber Reads
← Back ◬ AI & Machine Learning Jun 17, 2026

Treatment Response Optimized Clinical Decision Support AI System via Digital Twin Simulation

arXiv AI Archived Jun 17, 2026 ✓ Full text saved

arXiv:2606.17405v1 Announce Type: new Abstract: Clinical decision support AI systems (CDSASs) must adapt to evolving patient conditions in real-time while adhering to strict safety constraints. We present an online adaptive framework that integrates Treatment Effect (TE) estimation to quantify clinical benefits, a patient Digital Twin (DT) to simulate treatment trajectories, and Reinforcement Learning (RL) for sequential decision-making. The AI system is initially trained on historical medical r

Full text archived locally
✦ AI Summary · Claude Sonnet


    Computer Science > Artificial Intelligence [Submitted on 16 Jun 2026] Treatment Response Optimized Clinical Decision Support AI System via Digital Twin Simulation Xinyu Qin, Anil K. Sood, Ruiheng Yu, Sara Corvigno, Elaine Stur, Lu Wang Clinical decision support AI systems (CDSASs) must adapt to evolving patient conditions in real-time while adhering to strict safety constraints. We present an online adaptive framework that integrates Treatment Effect (TE) estimation to quantify clinical benefits, a patient Digital Twin (DT) to simulate treatment trajectories, and Reinforcement Learning (RL) for sequential decision-making. The AI system is initially trained on historical medical records and operates in a continuous learning loop. To ensure safety, a rule-based module monitors vital signs and blocks contraindicated treatments. Cases with strong internal model disagreement are flagged for clinician review, simulated in our experiments via a pre-trained outcome model. We validate our framework using both a synthetic clinical simulator and a real-world ovarian cancer dataset from The Cancer Genome Atlas (TCGA). In both simulated and clinical settings, our method demonstrated superior effectiveness and stability in recommending treatments compared to standard computational baselines. Furthermore, the AI system maintains low latency and requires expert consultation for only a minority of cases in our experimental validation, demonstrating its potential as a safe, clinician-supervised tool for personalized medicine that continuously improves through practical use. Comments: Accepted for presentation at the IEEE Engineering in Medicine and Biology Conference (EMBC) 2026 Subjects: Artificial Intelligence (cs.AI) Cite as: arXiv:2606.17405 [cs.AI]   (or arXiv:2606.17405v1 [cs.AI] for this version)   https://doi.org/10.48550/arXiv.2606.17405 Focus to learn more Submission history From: Xinyu Qin [view email] [v1] Tue, 16 Jun 2026 01:39:55 UTC (1,674 KB) Access Paper: HTML (experimental) view license Current browse context: cs.AI < prev   |   next > new | recent | 2026-06 Change to browse by: cs References & Citations NASA ADS Google Scholar Semantic Scholar Export BibTeX Citation Bookmark Bibliographic Tools Bibliographic and Citation Tools Bibliographic Explorer Toggle Bibliographic Explorer (What is the Explorer?) Connected Papers Toggle Connected Papers (What is Connected Papers?) Litmaps Toggle Litmaps (What is Litmaps?) scite.ai Toggle scite Smart Citations (What are Smart Citations?) Code, Data, Media Demos Related Papers About arXivLabs Which authors of this paper are endorsers? | Disable MathJax (What is MathJax?)
    💬 Team Notes
    Article Info
    Source
    arXiv AI
    Category
    ◬ AI & Machine Learning
    Published
    Jun 17, 2026
    Archived
    Jun 17, 2026
    Full Text
    ✓ Saved locally
    Open Original ↗